Single 100ml blood sample
Research type
Research Study
Full title
Study of interactions between cancer and the immune system
IRAS ID
238448
Contact name
Poulam Patel
Contact email
Sponsor organisation
University of Nottingham
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
50% of people born in the UK since 1960 will develop cancer during their lifetime and 450 people a day in the UK die from cancer. A new approach for treatment is to ‘switch on’ the patient’s own immune system to attack their cancer in the same way that the immune system fights off infections, rather than using conventional chemotherapy treatments. This approach is called Cancer Immunotherapy and is in routine use for lung cancer, kidney cancer and melanoma and is looking promising for a range of other cancers. However, Cancer Immunotherapy does not work in everybody or in all cancers, and several ways that the tumour can avoid the immune system have already been identified. Groups in our department are trying to identify other ways in which tumours evade the immune system and develop treatments to stop this from happening. This has the potential to improve survival across a range of cancer types and increase the number of people who can benefit from Cancer Immunotherapy.
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
18/NW/0541
Date of REC Opinion
23 Jul 2018
REC opinion
Further Information Favourable Opinion